SLI
2.083,81
PKT
-1,26
PKT
-0,06
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.01.23 | Nestlé Hold | Jefferies & Company Inc. | |
17.01.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
17.01.23 | Richemont Outperform | RBC Capital Markets | |
17.01.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
17.01.23 | Swatch (I) Buy | Jefferies & Company Inc. | |
16.01.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
16.01.23 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
13.01.23 | Nestlé Buy | UBS AG | |
13.01.23 | UBS Underweight | Barclays Capital | |
13.01.23 | UBS Underweight | Barclays Capital | |
13.01.23 | UBS Hold | Deutsche Bank AG | |
13.01.23 | Zurich Insurance Hold | Jefferies & Company Inc. | |
13.01.23 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
12.01.23 | Zurich Insurance Buy | UBS AG | |
12.01.23 | Swiss Re Sell | UBS AG | |
12.01.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
12.01.23 | Nestlé Buy | Deutsche Bank AG | |
12.01.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
11.01.23 | UBS Neutral | UBS AG | |
11.01.23 | UBS Buy | Goldman Sachs Group Inc. | |
11.01.23 | Nestlé Buy | Goldman Sachs Group Inc. | |
10.01.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
10.01.23 | Richemont Outperform | RBC Capital Markets | |
10.01.23 | Zurich Insurance Hold | Deutsche Bank AG | |
09.01.23 | Roche Neutral | UBS AG | |
09.01.23 | Novartis Neutral | UBS AG | |
09.01.23 | Richemont Buy | UBS AG | |
09.01.23 | Givaudan Underperform | Bernstein Research | |
07.01.23 | UBS Neutral | Credit Suisse Group | |
06.01.23 | ams-OSRAM Hold | Jefferies & Company Inc. | |
06.01.23 | Roche Outperform | Credit Suisse Group | |
06.01.23 | Novartis Underperform | Credit Suisse Group | |
06.01.23 | Novartis Underweight | Morgan Stanley | |
06.01.23 | UBS Outperform | RBC Capital Markets | |
05.01.23 | UBS Overweight | JP Morgan Chase & Co. | |
05.01.23 | Swiss Re Sector Perform | RBC Capital Markets | |
05.01.23 | Richemont Market-Perform | Bernstein Research | |
05.01.23 | Richemont Overweight | Barclays Capital | |
05.01.23 | Novartis Buy | Jefferies & Company Inc. | |
05.01.23 | Roche Hold | Jefferies & Company Inc. |